CCM
AGN

Conatus Capital Management’s Allergan plc AGN Stock Holding History

Conatus Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-304,219
Closed -$81.5M – 29
2016
Q1 		$81.5M Sell
304,219
-69,868
-19% -$20M 5.29% 7
2015
Q4 		$117M Sell
374,087
-28,179
-7% -$8.39M 7.69% 2
2015
Q3 		$109M Sell
402,266
-62,513
-13% -$19.2M 6.91% 3
2015
Q2 		$141M Buy
464,779
+59,987
+15% +$17.9M 8.59% 1
2015
Q1 		$120M Sell
404,792
-162,429
-29% -$46.3M 7.62% 2
2014
Q4 		$146M Sell
567,221
-131,946
-19% -$33M 7.13% 3
2014
Q3 		$169M Buy
699,167
+160,782
+30% +$36M 7.21% 2
2014
Q2 		$120M Buy
+538,385
New +$111M 5.54% 7

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Conatus Capital Management's AGN Position: Q2 2016 in Review

Conatus Capital Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 304,219 shares — an estimated $81.5M sold.

Conatus Capital Management first reported a position in AGN in Q2 2014 and held it in 8 quarters. The position peaked at $169M in Q3 2014. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Conatus Capital Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Conatus Capital Management sold 304,219 Allergan plc shares in Q2 2016, an estimated $81.5M.
  • Conatus Capital Management first reported a position in Allergan plc in Q2 2014 and held it in 8 quarters.
  • Conatus Capital Management's Allergan plc position peaked at $169M in Q3 2014.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Conatus Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.